Why Tyme Technologies Stock Is Crushing It Today
Shares of Tyme Technologies (NASDAQ: TYME) were skyrocketing 84.9% higher as of 12:09 p.m. EST on Wednesday after rising as much as 174% earlier in the day. This huge gain came after the company announced that the U.S. Patent and Trademark Office (USPTO) had granted another patent related to a COVID-19 treatment using Tyme's metabolomic technology platform.
It's not unusual for clinical-stage biotech stocks like Tyme to go into orbit after good news. But just how good was Tyme's news? The answer lies in how its metabolomic technology works.
Image source: Getty Images.
Source Fool.com
